These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 19682581

  • 1. Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production.
    Pope AJ, Karuppiah K, Cardounel AJ.
    Pharmacol Res; 2009 Dec; 60(6):461-5. PubMed ID: 19682581
    [Abstract] [Full Text] [Related]

  • 2. Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production.
    Pope AJ, Karrupiah K, Kearns PN, Xia Y, Cardounel AJ.
    J Biol Chem; 2009 Dec 18; 284(51):35338-47. PubMed ID: 19820234
    [Abstract] [Full Text] [Related]

  • 3. Asymmetric dimethylarginine, endothelial dysfunction and renal disease.
    Aldámiz-Echevarría L, Andrade F.
    Int J Mol Sci; 2012 Dec 18; 13(9):11288-11311. PubMed ID: 23109853
    [Abstract] [Full Text] [Related]

  • 4. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor.
    Böger RH.
    Cardiovasc Res; 2003 Oct 01; 59(4):824-33. PubMed ID: 14553822
    [Abstract] [Full Text] [Related]

  • 5. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
    Sakurada M, Shichiri M, Imamura M, Azuma H, Hirata Y.
    Hypertension; 2008 Nov 01; 52(5):903-9. PubMed ID: 18824664
    [Abstract] [Full Text] [Related]

  • 6. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor.
    Böger RH.
    J Nutr; 2004 Oct 01; 134(10 Suppl):2842S-2847S; discussion 2853S. PubMed ID: 15465797
    [Abstract] [Full Text] [Related]

  • 7. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity.
    Jiang JL, Zhang XH, Li NS, Rang WQ, Feng-Ye, Hu CP, Li YJ, Deng HW.
    Cardiovasc Drugs Ther; 2006 Aug 01; 20(4):281-94. PubMed ID: 16897158
    [Abstract] [Full Text] [Related]

  • 8. Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine--an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction.
    McCarty MF.
    Med Hypotheses; 2004 Aug 01; 63(4):699-708. PubMed ID: 15325021
    [Abstract] [Full Text] [Related]

  • 9. Association of asymmetric dimethylarginine and endothelial dysfunction.
    Böger RH.
    Clin Chem Lab Med; 2003 Nov 01; 41(11):1467-72. PubMed ID: 14656027
    [Abstract] [Full Text] [Related]

  • 10. PRMT-1 and DDAHs-induced ADMA upregulation is involved in ROS- and RAS-mediated diabetic retinopathy.
    Chen Y, Xu X, Sheng M, Zhang X, Gu Q, Zheng Z.
    Exp Eye Res; 2009 Dec 01; 89(6):1028-34. PubMed ID: 19748504
    [Abstract] [Full Text] [Related]

  • 11. Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction.
    Jiang DJ, Jia SJ, Yan J, Zhou Z, Yuan Q, Li YJ.
    Biochem Biophys Res Commun; 2006 Oct 20; 349(2):683-93. PubMed ID: 16959216
    [Abstract] [Full Text] [Related]

  • 12. Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in pre-eclampsia.
    Anderssohn M, Maass LM, Diemert A, Lüneburg N, Atzler D, Hecher K, Böger RH.
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr 20; 161(2):152-6. PubMed ID: 22285683
    [Abstract] [Full Text] [Related]

  • 13. Estradiol, acting through estrogen receptor alpha, restores dimethylarginine dimethylaminohydrolase activity and nitric oxide production in oxLDL-treated human arterial endothelial cells.
    Novella S, Laguna-Fernández A, Lázaro-Franco M, Sobrino A, Bueno-Betí C, Tarín JJ, Monsalve E, Sanchís J, Hermenegildo C.
    Mol Cell Endocrinol; 2013 Jan 05; 365(1):11-6. PubMed ID: 22982060
    [Abstract] [Full Text] [Related]

  • 14. Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs.
    Liu H, Qu X, Liang Z, Chen W, Xia W, Song Y.
    Biochem Biophys Res Commun; 2008 Dec 19; 377(3):884-8. PubMed ID: 18951871
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
    Dayoub H, Rodionov RN, Lynch C, Cooke JP, Arning E, Bottiglieri T, Lentz SR, Faraci FM.
    Stroke; 2008 Jan 19; 39(1):180-4. PubMed ID: 18063827
    [Abstract] [Full Text] [Related]

  • 16. Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA).
    Maas R.
    Vasc Med; 2005 Jul 19; 10 Suppl 1():S49-57. PubMed ID: 16444869
    [Abstract] [Full Text] [Related]

  • 17. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.
    Palm F, Onozato ML, Luo Z, Wilcox CS.
    Am J Physiol Heart Circ Physiol; 2007 Dec 19; 293(6):H3227-45. PubMed ID: 17933965
    [Abstract] [Full Text] [Related]

  • 18. Impact of high salt independent of blood pressure on PRMT/ADMA/DDAH pathway in the aorta of Dahl salt-sensitive rats.
    Cao Y, Mu JJ, Fang Y, Yuan ZY, Liu FQ.
    Int J Mol Sci; 2013 Apr 12; 14(4):8062-72. PubMed ID: 23584024
    [Abstract] [Full Text] [Related]

  • 19. Protective effect of HDL on endothelial NO production: the role of DDAH/ADMA pathway.
    Peng ZY, Zhao SP, He BM, Peng DQ, Hu M.
    Mol Cell Biochem; 2011 May 12; 351(1-2):243-9. PubMed ID: 21264497
    [Abstract] [Full Text] [Related]

  • 20. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.
    Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, Tsuji H, Reaven GM, Cooke JP.
    Circulation; 2002 Aug 20; 106(8):987-92. PubMed ID: 12186805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.